Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
2008

Mycoplasmas Degrade Amyloid-beta in Cell Cultures

publication Evidence: moderate

Author Information

Author(s): Zhao Haitian, Dreses-Werringloer Ute, Davies Peter, Marambaud Philippe

Primary Institution: Litwin-Zucker Research Center for the Study of Alzheimer Disease, The Feinstein Institute for Medical Research, North Shore-LIJ, Manhasset, NY, USA

Hypothesis

Do mycoplasma contaminants in cell cultures affect the levels of amyloid-beta?

Conclusion

Mycoplasmas degrade amyloid-beta and can significantly alter its levels in cell cultures.

Supporting Evidence

  • Mycoplasmas can rapidly degrade extracellular amyloid-beta in cell cultures.
  • Eradication of mycoplasma contaminants restores amyloid-beta accumulation in APP-transfected cells.
  • Up to 35% of cell cultures may be infected with mycoplasmas, affecting research outcomes.

Takeaway

Mycoplasmas are tiny germs that can mess up experiments by breaking down a protein called amyloid-beta, which is important for studying Alzheimer's disease.

Methodology

The study involved analyzing the effects of mycoplasma contamination on amyloid-beta levels in cell cultures using various treatments and assessments.

Limitations

The study primarily focuses on one type of mycoplasma and its effects, which may not represent all mycoplasma species.

Digital Object Identifier (DOI)

10.1186/1756-0500-1-38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication